Bonus BioGroup (XTAE:BONS) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:BONS Bonus BioGroup Ltd XTAE:BONS
22 GF Score
Price ₪0.27
! 3 Warning Signs
View Full Analysis

What is Bonus BioGroup FFO?

FFO (Funds from operations) only applies to REITs.

XTAE:BONS
22GF Score
Bonus BioGroup Ltd XTAE:BONS
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bonus BioGroup Business Description

Other Exchanges BBIXF:USA
Address Matam Advanced, Technology Park, P.O.B 15143, Haifa, ISR, 31905
Bonus BioGroup Ltd is an clinical-stage biotechnology company developing next-generation therapies for a variety of indications in the regenerative medicine field. Its products products, BonoFill and MesenCure.
22GF Score

Get the complete analysis for XTAE:BONS

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪0.27
Price